ARTICLE | Company News
Ardent, J&J deal
November 8, 2004 8:00 AM UTC
Ardent granted JNJ subsidiary Alza Corp. (Mountain View, Calif.) a 12-month option to an exclusive worldwide license to DPI-125, a delta/ mu opioid receptor agonist that has completed Phase I testing...